tirzepatide and hrt Postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a drug for overweight obesity treatment, according to a new study led by Mayo Clinic. ⁣ ⁣ The Hormone Therapy Supercharges Tirzepatide: A

DOI: 10.3389/fphys.2012.00161 Yahiya Y.I., Hadi N.R., Abu Raghif A., Qassam H., Al Habooby N.G.S

The FDA on Friday accepted Novo Nordisk s New Drug Application for an oral formulation of its widely popular obesity drug Wegovy for chronic weight management, bringing the Danish drugmaker one step closer to winning the first regulatory approval for a GLP-1 pill specifically for weight-loss

Hormonal changes, such as those experienced during menstruation or menopause, can also contribute to the frequency and intensity of palpitations, as fluctuations in hormone levels can affect heart rhythm

Effects of a 4-week very low-carbohydrate diet on high-intensity interval training responses

Use liner to lift corners slightly for balance